These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 17593217
1. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Ihrler S, Weiler C, Hirschmann A, Sendelhofert A, Lang S, Guntinas-Lichius O, Arnold G, Zietz C, Harrison JD. Histopathology; 2007 Sep; 51(3):362-71. PubMed ID: 17593217 [Abstract] [Full Text] [Related]
2. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases. Weiler C, Zengel P, van der Wal JE, Guntinas-Lichius O, Schwarz S, Harrison JD, Kirchner T, Ihrler S. Histopathology; 2011 Oct; 59(4):741-50. PubMed ID: 22014054 [Abstract] [Full Text] [Related]
3. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Di Palma S, Skálová A, Vanìèek T, Simpson RH, Stárek I, Leivo I. Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886 [Abstract] [Full Text] [Related]
4. Histological, immunohistological and molecular characteristics of intraductal precursor of carcinoma ex pleomorphic adenoma support a multistep carcinogenic process. Ihrler S, Guntinas-Lichius O, Agaimy A, Wolf A, Mollenhauer M. Virchows Arch; 2017 Jun; 470(6):601-609. PubMed ID: 28353089 [Abstract] [Full Text] [Related]
5. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Altemani A, Martins MT, Freitas L, Soares F, Araújo NS, Araújo VC. Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594 [Abstract] [Full Text] [Related]
6. The role of the p53 gene in the malignant transformation of pleomorphic adenomas of the parotid gland. Righi PD, Li YQ, Deutsch M, McDonald JS, Wilson KM, Bejarano P, Stambrook PJ, Osterhage D, Nguyen C, Gluckman JL. Anticancer Res; 1994 Jun; 14(5B):2253-7. PubMed ID: 7840532 [Abstract] [Full Text] [Related]
7. S100P expression in ductal type of carcinoma ex pleomorphic adenoma. Hashimoto K, Yamamoto H, Shiratsuchi H, Nakashima T, Tamiya S, Higaki Y, Komune S, Tsuneyoshi M, Oda Y. Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706 [Abstract] [Full Text] [Related]
8. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma. Hoch BL, Wu M, Lewis M, Gan L, Burstein DE. J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415 [Abstract] [Full Text] [Related]
9. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy. Félix A, Rosa JC, Fonseca I, Cidadão A, Soares J. Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638 [Abstract] [Full Text] [Related]
10. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma. de Araújo VC, Altemani A, Furuse C, Martins MT, de Araújo NS. Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205 [Abstract] [Full Text] [Related]
11. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Lewis JE, Olsen KD, Sebo TJ. Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714 [Abstract] [Full Text] [Related]
12. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma. Katori H, Nozawa A, Tsukuda M. Auris Nasus Larynx; 2007 Mar; 34(1):79-84. PubMed ID: 17049779 [Abstract] [Full Text] [Related]
13. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study. Hashimoto K, Yamamoto H, Shiratsuchi H, Nakashima T, Tamiya S, Nishiyama K, Higaki Y, Komune S, Tsuneyoshi M, Oda Y. Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195 [Abstract] [Full Text] [Related]
14. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma. Katori H, Nozawa A, Tsukuda M. Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915 [Abstract] [Full Text] [Related]
15. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I. Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717 [Abstract] [Full Text] [Related]
16. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM. J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354 [Abstract] [Full Text] [Related]
17. Pleomorphic adenoma of oral minor salivary glands: An investigation of its neoplastic potential based on apoptosis, mucosecretory activity and cellular proliferation. Ferreira JC, Morais MO, Elias MR, Batista AC, Leles CR, Mendonça EF. Arch Oral Biol; 2014 Jun; 59(6):578-85. PubMed ID: 24681706 [Abstract] [Full Text] [Related]
18. [Quantitative studies of oncogene ras P21 and P53 gene protein expression in the benign and malignant pleomorphic adenomas of salivary gland]. Wang J, Dong F, Wang X. Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jul; 32(4):208-11. PubMed ID: 10680505 [Abstract] [Full Text] [Related]
19. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study. do Prado RF, Consolaro A, Taveira LA. Med Oral Patol Oral Cir Bucal; 2006 May 01; 11(3):E247-51. PubMed ID: 16648762 [Abstract] [Full Text] [Related]
20. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. Di Palma S. Head Neck Pathol; 2013 Jul 01; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206 [Abstract] [Full Text] [Related] Page: [Next] [New Search]